Aesthetic Device Clearance Tracker: FDA-Cleared Energy Devices

Most aesthetic energy devices clear via 510(k) (substantial equivalence to a predicate device), a faster pathway that requires demonstration of safety and effectiveness but not large clinical trials. A few premium or novel devices pursue PMA (Premarket Approval), which demands rigorous clinical data and results in a broader, more defensible cleared indication. RF microneedling devices like InMode Morpheus8 and Cutera Secret RF typically clear via 510(k) by claiming equivalence to earlier RF or microneedling devices. Laser systems (ablative and non-ablative) have long been 510(k)-cleared; the predicate pool is deep. Ultrasound devices (e.g., Ultherapy) often clear via 510(k) as well. The pathway does not determine clinical quality, but it does affect the breadth and defensibility of your cleared indications. A 510(k) clearance is narrower and more specific than a PMA; a vendor claiming a 510(k) device can treat "all signs of aging" is misrepresenting the clearance.

Monopolar RF devices (e.g., Thermage, Cutera Pelleve, and newer entrants like Cynosure Lutronic's next-generation monopolar RF) are typically cleared for temporary reduction of the appearance of wrinkles and sometimes temporary tightening of skin. The word "temporary" is critical: it reflects the FDA's view that results are not permanent. Cleared indications do not include fat reduction, cellulite treatment, or body contouring, though some practices market off-label use. Bipolar and multipolar RF (fractional RF, RF microneedling) have narrower cleared indications, often limited to wrinkle reduction or skin resurfacing. Always verify the exact indication in the device's 510(k) summary on the FDA website; vendor marketing materials routinely broaden the language. For example, a device cleared for "temporary reduction of the appearance of facial wrinkles" cannot legally be marketed for neck tightening or body skin laxity without an FDA submission or explicit off-label disclosure.

Ablative lasers (CO₂, erbium) clear for resurfacing, wrinkle reduction, and scar revision. Non-ablative lasers (Nd:YAG, diode, alexandrite) typically clear for hair removal, vascular lesions, and pigmented lesions; some also clear for collagen remodeling and wrinkle reduction. Fractional lasers (ablative and non-ablative) clear for similar indications but with the added benefit of reduced downtime. The FDA does not separately clear a device for "skin tightening" via laser; vendors often claim this off-label. Combination devices (e.g., laser + RF, laser + microneedling) require separate 510(k) submissions for each modality or a combined submission; do not assume a laser clearance extends to RF or vice versa. Check the device's K-number (e.g., K123456) on the FDA's 510(k) database to confirm the exact cleared indication and predicate device.

Microfocused ultrasound (Ultherapy, and similar devices) clears via 510(k) for non-invasive skin tightening and lifting of the eyebrow, neck, and décolletage. The indication is specific to anatomical zones; a device cleared for the face is not automatically cleared for the body. Ultrasound devices are among the few with a "tightening" indication that the FDA explicitly allows. However, the cleared indication does not extend to fat reduction or cellulite; off-label marketing of these uses exposes the practice to regulatory action. Verify the device's cleared anatomical zones and depth of penetration in the 510(k) summary. Some newer ultrasound devices claim enhanced depth or speed; confirm these claims are reflected in the FDA clearance, not merely in vendor white papers.

Microneedling alone (non-RF) typically clears for collagen induction and improvement of the appearance of scars and wrinkles. RF microneedling (e.g., Morpheus8, Secret RF, Vivace) clears for similar indications but often with broader language around skin resurfacing and texture. The depth of penetration and energy delivery are specified in the 510(k); a device cleared for 2.5 mm depth cannot legally be marketed for deeper subdermal remodeling. Fractional microneedling devices are often cleared via 510(k) by claiming equivalence to earlier fractional RF or laser devices. Verify the cleared depth, energy range, and anatomical zones (face vs. body). Off-label use for cellulite, stretch marks, or body contouring is common but not cleared; do not market these uses without explicit disclaimers.

Step 1: Visit the FDA's 510(k) database (fda.gov/cdrh/k-series.html) or search by device name or K-number. Step 2: Locate the device's 510(k) summary and predicate device. Step 3: Read the "Indications for Use" section word-for-word; this is the legal boundary. Step 4: Cross-check the vendor's marketing claims against the indications. Red flags: claims of "permanent" results (FDA clears only "temporary"), indications not listed (e.g., cellulite, fat reduction), or vague language like "skin rejuvenation" without specificity. Step 5: If a device is new or you cannot find it, ask the vendor for the K-number and 510(k) summary in writing before purchase. Reputable manufacturers provide this without hesitation. If a vendor resists or claims the clearance is proprietary, escalate to your legal counsel. Document all clearance verification in your compliance file; regulators expect practices to have done due diligence.